Clinical Trial Update: Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of tremelimumab in previously treated metastatic urothelial cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Tremelimumab (tremelimumab)

Snippet

Sponsor: Matthew Galsky | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-07-03